MS Forums 2026- Module III: Al Ain Neuroscience Club in collaboration with MENACTRIMS The New MS Standard: From Family Planning Safety to Pediatric Efficacy

MS Forums 2026- Module II: Anti-CD20 in MS: What’s New?

MS Forums 2026- Module I: Immune Reconstitution Therapy in Multiple Sclerosis: From Science to Real-World Practice

MS Forums 2025- Module V: Evolving Paradigms in NMOSD: From Biomarkers to Breakthroughs

MS Forums 2025- Module IV: Optimizing Treatment Choice in NMOSD

MS Forums 2025- Module III: Al Ain Neuroscience Club in collaboration with MENACTRIMS

MS Forums 2025- Module II: Anti-CD20 Treatment Beyond B-cell Depletion

MS Forums 2025- Module I: Advancing MS Care: Diagnosis, Treatment, and Digital Innovations

MS Forums 2024- Module I: How Immune Reconstitution Therapy has Transformed MS Management

MS Forums 2024- Module II: Anti-CD20 Treatment Beyond B-cell Depletion

MS Forums 2024- Module III: Al Ain Neuroscience Club in collaboration with MENACTRIMS

MS Forums 2024- Module IV:
Optimizing Treatment Choice in NMOSD

MS Forums 2024- Module V: Transforming MS Care: The Role of Early Intervention and Long-Term Safety

MS Forums 2023- Module I: Infections and Vaccination in MS: An Update

MS Forums 2023- Module II: Escalating and De-escalating Disease-Modifying Therapies

MS Forums 2023- Module III: Novel Therapies for NMOSD

MS Forums 2023- Module IV:
Hot Topics in MS Today